Subsequently, we employed these modified cells to investigate the impact of tumor cell-intrinsic ATP6V0A1 on suppressing anti-tumor immunity in syngeneic and xenograft mouse models of CRC (Supplementary Fig. 6). This evidence concerns the gene ATP6V0A1 and colorectal carcinoma.